Stay updated on Psilocybin vs Escitalopram for MDD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.

Latest updates to the Psilocybin vs Escitalopram for MDD Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site footer revision advanced from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record with a standard error page and blocking access to the trial details. This effectively hides core content that users rely on to view the study information.SummaryDifference19%

- Check52 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This is a metadata/version update and does not modify the study content presented on the page.SummaryDifference0.1%

- Check59 days agoChange DetectedA line reading '2017 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, reflecting NIH funding for the trial.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This reflects a minor update to the page's template or metadata rather than substantive content.SummaryDifference0.1%

Stay in the know with updates to Psilocybin vs Escitalopram for MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Escitalopram for MDD Clinical Trial page.